Share
Cancer is a leading cause of death in Virginia and researchers at the University of Virginia’s Weldon Cooper Center for Public Service project that the rate of growth in new cancer cases will far outpace the growth of the population in the next 25 years, due to the overall aging of the population.
Share
Virginia Tech Carilion Research Institute scientists have developed new imaging techniques to watch dangerous brain tumor cells respond to treatment in real time.
Share
In a breakthrough in the understanding of how cancer does its deadly work, researchers at the University of Virginia School of Medicine have shown that many cancers – including nearly all pancreatic cancers – enslave and deform mitochondria, the powerhouses of cells, to create an environment more conducive to tumor growth.
Share
On Monday, March 30, 2015, The Paramount Theater will host a live screening of the PBS film premiere, brought to you by UVA Cancer Center in partnership with WVPT Public Television, the American Cancer Society, and The Paramount Theater.
Share
Important news for men receiving treatment for prostate cancer: Two new studies from the University of Virginia School of Medicine have upended the widely held view that it’s best to delay radiation treatment as long as possible after the removal of the prostate in order to prevent unwanted side effects.
Share
For meeting national quality and patient safety standards, UVA Cancer Center has been awarded a three-year accreditation in radiation oncology by the American College of Radiology (ACR).
Share
Scott Gronert, Ph.D., a chemistry professor at Virginia Commonwealth University, has been awarded a prestigious Fulbright Scholar award to work with researchers in France on a new process that could help surgeons more accurately remove cancerous cells.
Share
UVA Cancer Center is now one of six U.S. cancer centers in a national cancer research network that aims to develop more personalized treatments for cancer.
Share
Biologists working with engineers and physicists have found a molecule they said helps determine if breast cancer cells that are resistant to antiestrogen therapy will live or die.
Share
A team of researchers has devised a new way to target tumors with cancer-fighting drugs, a discovery that may lead to clinical treatments for cancer patients.
Our content is free to read, but we do have bills to pay. Pitch in and help us keep the community informed.